Trial intelligence / Profile preview

BTFC in Exfoliative Glaucoma

NCT00486486Phase 4Completed

Sponsor
Aristotle University of Thessaloniki
Start
Mar 2007
Primary completion
May 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of bimatoprost, timolol in pseudoexfoliative glaucoma (PEXG), sponsored by Aristotle University of Thessaloniki. Started Mar 2007; status: completed.

02

Drugs

bimatoprosttimolol
03

Conditions

pseudoexfoliative glaucoma (PEXG)

Beyond the preview

Go deeper on NCT00486486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00486486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call